APO Research
Talk to an analyst

APO RESEARCH · REPORT

Subcutaneous Injection Immunoglobulin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Subcutaneous Injection Immunoglobulin Industry Growth and Trends Forecast to 2032

20 December 202578 pages

Choose your research edition.

Industry ResearchSubcutaneous Injection Immunoglobulin Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal Subcutaneous Injection Immunoglobulin Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Subcutaneous Injection Immunoglobulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Subcutaneous Injection Immunoglobulin Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Subcutaneous Injection Immunoglobulin Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Subcutaneous Injection Immunoglobulin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Subcutaneous Injection Immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Subcutaneous Injection Immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Subcutaneous Injection Immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Subcutaneous Injection Immunoglobulin include Takeda, Grifols and CSL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Subcutaneous Injection Immunoglobulin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Subcutaneous Injection Immunoglobulin market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Subcutaneous Injection Immunoglobulin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Subcutaneous Injection Immunoglobulin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Subcutaneous Injection Immunoglobulin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Subcutaneous Injection Immunoglobulin Market by Company

Takeda

Grifols

CSL

Subcutaneous Injection Immunoglobulin Segment by Type

10% Purity

20% Purity

Subcutaneous Injection Immunoglobulin Segment by Application

Primary Immunodeficiency

Secondary Immunodeficiency

Others

Subcutaneous Injection Immunoglobulin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Subcutaneous Injection Immunoglobulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Subcutaneous Injection Immunoglobulin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Subcutaneous Injection Immunoglobulin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Subcutaneous Injection Immunoglobulin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Subcutaneous Injection Immunoglobulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 10% Purity Table 2. Major Company of 20% Purity Table 3. Global Subcutaneous Injection Immunoglobulin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Subcutaneous Injection Immunoglobulin Sales by Type (2021-2026) & (k units) Table 5. Global Subcutaneous Injection Immunoglobulin Sales Market Share in Volume by Type (2021-2026) Table 6. Global Subcutaneous Injection Immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 7. Global Subcutaneous Injection Immunoglobulin Sales Market Share in Value by Type (2021-2026) Table 8. Global Subcutaneous Injection Immunoglobulin Price by Type (2021-2026) & (US$/unit) Table 9. Global Subcutaneous Injection Immunoglobulin Sales by Type (2027-2032) & (k units) Table 10. Global Subcutaneous Injection Immunoglobulin Sales Market Share in Volume by Type (2027-2032) Table 11. Global Subcutaneous Injection Immunoglobulin Sales by Type (2027-2032) & (US$ Million) Table 12. Global Subcutaneous Injection Immunoglobulin Sales Market Share in Value by Type (2027-2032) Table 13. Global Subcutaneous Injection Immunoglobulin Price by Type (2027-2032) & (US$/unit) Table 14. North America Subcutaneous Injection Immunoglobulin Sales by Type (2021-2026) & (k units) Table 15. North America Subcutaneous Injection Immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Subcutaneous Injection Immunoglobulin Sales by Type (2021-2026) & (k units) Table 17. Europe Subcutaneous Injection Immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Subcutaneous Injection Immunoglobulin Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Subcutaneous Injection Immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Subcutaneous Injection Immunoglobulin Sales by Type (2021-2026) & (k units) Table 21. Latin America Subcutaneous Injection Immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 24. Subcutaneous Injection Immunoglobulin Industry Trends Table 25. Subcutaneous Injection Immunoglobulin Industry Drivers Table 26. Subcutaneous Injection Immunoglobulin Industry Opportunities and Challenges Table 27. Subcutaneous Injection Immunoglobulin Industry Restraints Table 28. Global Subcutaneous Injection Immunoglobulin Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Company (2021-2026) Table 30. Global Subcutaneous Injection Immunoglobulin Sales by Company (2021-2026) & (k units) Table 31. Global Subcutaneous Injection Immunoglobulin Sales Share by Company (2021-2026) Table 32. Global Subcutaneous Injection Immunoglobulin Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Subcutaneous Injection Immunoglobulin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Subcutaneous Injection Immunoglobulin Major Company Production Sites and Headquarters Table 35. Global Subcutaneous Injection Immunoglobulin Company, Product Type & Application Table 36. Global Subcutaneous Injection Immunoglobulin Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Subcutaneous Injection Immunoglobulin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Subcutaneous Injection Immunoglobulin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Subcutaneous Injection Immunoglobulin Sales by Region (2021-2026) & (k units) Table 41. Global Subcutaneous Injection Immunoglobulin Sales Market Share in Volume by Region (2021-2026) Table 42. Global Subcutaneous Injection Immunoglobulin Sales by Region (2021-2026) & (US$ Million) Table 43. Global Subcutaneous Injection Immunoglobulin Sales Market Share in Value by Region (2021-2026) Table 44. Global Subcutaneous Injection Immunoglobulin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Subcutaneous Injection Immunoglobulin Sales by Region (2027-2032) & (k units) Table 46. Global Subcutaneous Injection Immunoglobulin Sales Market Share in Volume by Region (2027-2032) Table 47. Global Subcutaneous Injection Immunoglobulin Sales by Region (2027-2032) & (US$ Million) Table 48. Global Subcutaneous Injection Immunoglobulin Sales Market Share in Value by Region (2027-2032) Table 49. Global Subcutaneous Injection Immunoglobulin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Subcutaneous Injection Immunoglobulin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Subcutaneous Injection Immunoglobulin Sales by Application (2021-2026) & (k units) Table 52. Global Subcutaneous Injection Immunoglobulin Sales Market Share in Volume by Application (2021-2026) Table 53. Global Subcutaneous Injection Immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 54. Global Subcutaneous Injection Immunoglobulin Sales Market Share in Value by Application (2021-2026) Table 55. Global Subcutaneous Injection Immunoglobulin Price by Application (2021-2026) & (US$/unit) Table 56. Global Subcutaneous Injection Immunoglobulin Sales by Application (2027-2032) & (k units) Table 57. Global Subcutaneous Injection Immunoglobulin Sales Market Share in Volume by Application (2027-2032) Table 58. Global Subcutaneous Injection Immunoglobulin Sales by Application (2027-2032) & (US$ Million) Table 59. Global Subcutaneous Injection Immunoglobulin Sales Market Share in Value by Application (2027-2032) Table 60. Global Subcutaneous Injection Immunoglobulin Price by Application (2027-2032) & (US$/unit) Table 61. North America Subcutaneous Injection Immunoglobulin Sales by Application (2021-2026) & (k units) Table 62. North America Subcutaneous Injection Immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Subcutaneous Injection Immunoglobulin Sales by Application (2021-2026) & (k units) Table 64. Europe Subcutaneous Injection Immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Subcutaneous Injection Immunoglobulin Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Subcutaneous Injection Immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Subcutaneous Injection Immunoglobulin Sales by Application (2021-2026) & (k units) Table 68. Latin America Subcutaneous Injection Immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 71. Takeda Company Information Table 72. Takeda Business Overview Table 73. Takeda Subcutaneous Injection Immunoglobulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Takeda Subcutaneous Injection Immunoglobulin Product Portfolio Table 75. Takeda Recent Development Table 76. Grifols Company Information Table 77. Grifols Business Overview Table 78. Grifols Subcutaneous Injection Immunoglobulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Grifols Subcutaneous Injection Immunoglobulin Product Portfolio Table 80. Grifols Recent Development Table 81. CSL Company Information Table 82. CSL Business Overview Table 83. CSL Subcutaneous Injection Immunoglobulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. CSL Subcutaneous Injection Immunoglobulin Product Portfolio Table 85. CSL Recent Development Table 86. North America Subcutaneous Injection Immunoglobulin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 87. North America Subcutaneous Injection Immunoglobulin Sales by Country (2021-2026) & (k units) Table 88. North America Subcutaneous Injection Immunoglobulin Sales Market Share by Country (2021-2026) Table 89. North America Subcutaneous Injection Immunoglobulin Sales Forecast by Country (2027-2032) & (k units) Table 90. North America Subcutaneous Injection Immunoglobulin Sales Market Share Forecast by Country (2027-2032) Table 91. North America Subcutaneous Injection Immunoglobulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. North America Subcutaneous Injection Immunoglobulin Market Size by Country (2021-2026) & (US$ Million) Table 93. North America Subcutaneous Injection Immunoglobulin Market Share by Country (2021-2026) Table 94. North America Subcutaneous Injection Immunoglobulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. North America Subcutaneous Injection Immunoglobulin Market Share Forecast by Country (2027-2032) Table 96. Europe Subcutaneous Injection Immunoglobulin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 97. Europe Subcutaneous Injection Immunoglobulin Sales by Country (2021-2026) & (k units) Table 98. Europe Subcutaneous Injection Immunoglobulin Sales Market Share by Country (2021-2026) Table 99. Europe Subcutaneous Injection Immunoglobulin Sales Forecast by Country (2027-2032) & (k units) Table 100. Europe Subcutaneous Injection Immunoglobulin Sales Market Share Forecast by Country (2027-2032) Table 101. Europe Subcutaneous Injection Immunoglobulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Europe Subcutaneous Injection Immunoglobulin Market Size by Country (2021-2026) & (US$ Million) Table 103. Europe Subcutaneous Injection Immunoglobulin Market Share by Country (2021-2026) Table 104. Europe Subcutaneous Injection Immunoglobulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Europe Subcutaneous Injection Immunoglobulin Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific Subcutaneous Injection Immunoglobulin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific Subcutaneous Injection Immunoglobulin Sales by Country (2021-2026) & (k units) Table 108. Asia-Pacific Subcutaneous Injection Immunoglobulin Sales Market Share by Country (2021-2026) Table 109. Asia-Pacific Subcutaneous Injection Immunoglobulin Sales Forecast by Country (2027-2032) & (k units) Table 110. Asia-Pacific Subcutaneous Injection Immunoglobulin Sales Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Subcutaneous Injection Immunoglobulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Subcutaneous Injection Immunoglobulin Market Size by Country (2021-2026) & (US$ Million) Table 113. Asia-Pacific Subcutaneous Injection Immunoglobulin Market Share by Country (2021-2026) Table 114. Asia-Pacific Subcutaneous Injection Immunoglobulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Asia-Pacific Subcutaneous Injection Immunoglobulin Market Share Forecast by Country (2027-2032) Table 116. Latin America Subcutaneous Injection Immunoglobulin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. Latin America Subcutaneous Injection Immunoglobulin Sales by Country (2021-2026) & (k units) Table 118. Latin America Subcutaneous Injection Immunoglobulin Sales Market Share by Country (2021-2026) Table 119. Latin America Subcutaneous Injection Immunoglobulin Sales Forecast by Country (2027-2032) & (k units) Table 120. Latin America Subcutaneous Injection Immunoglobulin Sales Market Share Forecast by Country (2027-2032) Table 121. Latin America Subcutaneous Injection Immunoglobulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Latin America Subcutaneous Injection Immunoglobulin Market Size by Country (2021-2026) & (US$ Million) Table 123. Latin America Subcutaneous Injection Immunoglobulin Market Share by Country (2021-2026) Table 124. Latin America Subcutaneous Injection Immunoglobulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Latin America Subcutaneous Injection Immunoglobulin Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa Subcutaneous Injection Immunoglobulin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales by Country (2021-2026) & (k units) Table 128. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales Market Share by Country (2021-2026) Table 129. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales Forecast by Country (2027-2032) & (k units) Table 130. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Subcutaneous Injection Immunoglobulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Subcutaneous Injection Immunoglobulin Market Size by Country (2021-2026) & (US$ Million) Table 133. Middle East and Africa Subcutaneous Injection Immunoglobulin Market Share by Country (2021-2026) Table 134. Middle East and Africa Subcutaneous Injection Immunoglobulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Middle East and Africa Subcutaneous Injection Immunoglobulin Market Share Forecast by Country (2027-2032) Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Subcutaneous Injection Immunoglobulin Distributors List Table 139. Subcutaneous Injection Immunoglobulin Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Subcutaneous Injection Immunoglobulin Image Figure 2. Global Subcutaneous Injection Immunoglobulin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Subcutaneous Injection Immunoglobulin Market Size (2021-2032) & (US$ Million) Figure 4. Global Subcutaneous Injection Immunoglobulin Sales (2021-2032) & (k units) Figure 5. 10% Purity Image Figure 6. Global 10% Purity Sales YoY Growth (2021-2032) & (k units) Figure 7. 20% Purity Image Figure 8. Global 20% Purity Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Subcutaneous Injection Immunoglobulin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Subcutaneous Injection Immunoglobulin Market Share by Type 2025 VS 2032 Figure 11. North America Subcutaneous Injection Immunoglobulin Sales Market Share in Volume by Type in 2025 Figure 12. North America Subcutaneous Injection Immunoglobulin Sales Market Share in Value by Type in 2025 Figure 13. Europe Subcutaneous Injection Immunoglobulin Sales Market Share in Volume by Type in 2025 Figure 14. Europe Subcutaneous Injection Immunoglobulin Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Subcutaneous Injection Immunoglobulin Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Subcutaneous Injection Immunoglobulin Sales Market Share in Value by Type in 2025 Figure 17. Latin America Subcutaneous Injection Immunoglobulin Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Subcutaneous Injection Immunoglobulin Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Subcutaneous Injection Immunoglobulin Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Primary Immunodeficiency Image Figure 24. Global Primary Immunodeficiency Sales YoY Growth (2021-2032) & (k units) Figure 25. Secondary Immunodeficiency Image Figure 26. Global Secondary Immunodeficiency Sales YoY Growth (2021-2032) & (k units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Subcutaneous Injection Immunoglobulin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Subcutaneous Injection Immunoglobulin Market Share by Application 2025 VS 2032 Figure 31. North America Subcutaneous Injection Immunoglobulin Sales Market Share in Volume by Application in 2025 Figure 32. North America Subcutaneous Injection Immunoglobulin Sales Market Share in Value by Application in 2025 Figure 33. Europe Subcutaneous Injection Immunoglobulin Sales Market Share in Volume by Application in 2025 Figure 34. Europe Subcutaneous Injection Immunoglobulin Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Subcutaneous Injection Immunoglobulin Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Subcutaneous Injection Immunoglobulin Sales Market Share in Value by Application in 2025 Figure 37. Latin America Subcutaneous Injection Immunoglobulin Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Subcutaneous Injection Immunoglobulin Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales Market Share in Value by Application in 2025 Figure 41. North America Subcutaneous Injection Immunoglobulin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Subcutaneous Injection Immunoglobulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Subcutaneous Injection Immunoglobulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Subcutaneous Injection Immunoglobulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Subcutaneous Injection Immunoglobulin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Subcutaneous Injection Immunoglobulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Subcutaneous Injection Immunoglobulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Subcutaneous Injection Immunoglobulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Subcutaneous Injection Immunoglobulin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Subcutaneous Injection Immunoglobulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Subcutaneous Injection Immunoglobulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Subcutaneous Injection Immunoglobulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Subcutaneous Injection Immunoglobulin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Subcutaneous Injection Immunoglobulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Subcutaneous Injection Immunoglobulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Subcutaneous Injection Immunoglobulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Subcutaneous Injection Immunoglobulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Subcutaneous Injection Immunoglobulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Subcutaneous Injection Immunoglobulin Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Subcutaneous Injection Immunoglobulin Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 10% Purity
  • 20% Purity
Applications
  • Primary Immunodeficiency
  • Secondary Immunodeficiency
  • Others
Companies covered
  • Takeda
  • Grifols
  • CSL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Subcutaneous Injection Immunoglobulin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Subcutaneous Injection Immunoglobulin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Subcutaneous Injection Immunoglobulin Market by Type
  6. 1.3.1 10% Purity
  7. 1.3.2 20% Purity
  8. 1.4 Global Subcutaneous Injection Immunoglobulin Market Size by Type
  9. 1.4.1 Global Subcutaneous Injection Immunoglobulin Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Subcutaneous Injection Immunoglobulin Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Subcutaneous Injection Immunoglobulin Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Subcutaneous Injection Immunoglobulin Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Subcutaneous Injection Immunoglobulin Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Subcutaneous Injection Immunoglobulin Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Subcutaneous Injection Immunoglobulin Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Subcutaneous Injection Immunoglobulin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Subcutaneous Injection Immunoglobulin Industry Trends
  2. 2.2 Subcutaneous Injection Immunoglobulin Industry Drivers
  3. 2.3 Subcutaneous Injection Immunoglobulin Industry Opportunities and Challenges
  4. 2.4 Subcutaneous Injection Immunoglobulin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Subcutaneous Injection Immunoglobulin Revenue (2021-2026)
  2. 3.2 Global Top Players by Subcutaneous Injection Immunoglobulin Sales (2021-2026)
  3. 3.3 Global Top Players by Subcutaneous Injection Immunoglobulin Price (2021-2026)
  4. 3.4 Global Subcutaneous Injection Immunoglobulin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Subcutaneous Injection Immunoglobulin Major Company Production Sites & Headquarters
  6. 3.6 Global Subcutaneous Injection Immunoglobulin Company, Product Type & Application
  7. 3.7 Global Subcutaneous Injection Immunoglobulin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Subcutaneous Injection Immunoglobulin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Subcutaneous Injection Immunoglobulin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Subcutaneous Injection Immunoglobulin Tier 1, Tier 2, and Tier 3
4 Subcutaneous Injection Immunoglobulin Regional Status and Outlook
  1. 4.1 Global Subcutaneous Injection Immunoglobulin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Subcutaneous Injection Immunoglobulin Historic Market Size by Region
  3. 4.2.1 Global Subcutaneous Injection Immunoglobulin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Subcutaneous Injection Immunoglobulin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Subcutaneous Injection Immunoglobulin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Subcutaneous Injection Immunoglobulin Forecasted Market Size by Region
  7. 4.3.1 Global Subcutaneous Injection Immunoglobulin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Subcutaneous Injection Immunoglobulin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Subcutaneous Injection Immunoglobulin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Subcutaneous Injection Immunoglobulin by Application
  1. 5.1 Subcutaneous Injection Immunoglobulin Market by Application
  2. 5.1.1 Primary Immunodeficiency
  3. 5.1.2 Secondary Immunodeficiency
  4. 5.1.3 Others
  5. 5.2 Global Subcutaneous Injection Immunoglobulin Market Size by Application
  6. 5.2.1 Global Subcutaneous Injection Immunoglobulin Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Subcutaneous Injection Immunoglobulin Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Subcutaneous Injection Immunoglobulin Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Subcutaneous Injection Immunoglobulin Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Subcutaneous Injection Immunoglobulin Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Subcutaneous Injection Immunoglobulin Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Subcutaneous Injection Immunoglobulin Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Subcutaneous Injection Immunoglobulin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Subcutaneous Injection Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Subcutaneous Injection Immunoglobulin Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Grifols
  8. 6.2.1 Grifols Company Information
  9. 6.2.2 Grifols Business Overview
  10. 6.2.3 Grifols Subcutaneous Injection Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Grifols Subcutaneous Injection Immunoglobulin Product Portfolio
  12. 6.2.5 Grifols Recent Developments
  13. 6.3 CSL
  14. 6.3.1 CSL Company Information
  15. 6.3.2 CSL Business Overview
  16. 6.3.3 CSL Subcutaneous Injection Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 CSL Subcutaneous Injection Immunoglobulin Product Portfolio
  18. 6.3.5 CSL Recent Developments
7 North America by Country
  1. 7.1 North America Subcutaneous Injection Immunoglobulin Sales by Country
  2. 7.1.1 North America Subcutaneous Injection Immunoglobulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Subcutaneous Injection Immunoglobulin Sales by Country (2021-2026)
  4. 7.1.3 North America Subcutaneous Injection Immunoglobulin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Subcutaneous Injection Immunoglobulin Market Size by Country
  6. 7.2.1 North America Subcutaneous Injection Immunoglobulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Subcutaneous Injection Immunoglobulin Market Size by Country (2021-2026)
  8. 7.2.3 North America Subcutaneous Injection Immunoglobulin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Subcutaneous Injection Immunoglobulin Sales by Country
  2. 8.1.1 Europe Subcutaneous Injection Immunoglobulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Subcutaneous Injection Immunoglobulin Sales by Country (2021-2026)
  4. 8.1.3 Europe Subcutaneous Injection Immunoglobulin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Subcutaneous Injection Immunoglobulin Market Size by Country
  6. 8.2.1 Europe Subcutaneous Injection Immunoglobulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Subcutaneous Injection Immunoglobulin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Subcutaneous Injection Immunoglobulin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Subcutaneous Injection Immunoglobulin Sales by Country
  2. 9.1.1 Asia-Pacific Subcutaneous Injection Immunoglobulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Subcutaneous Injection Immunoglobulin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Subcutaneous Injection Immunoglobulin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Subcutaneous Injection Immunoglobulin Market Size by Country
  6. 9.2.1 Asia-Pacific Subcutaneous Injection Immunoglobulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Subcutaneous Injection Immunoglobulin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Subcutaneous Injection Immunoglobulin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Subcutaneous Injection Immunoglobulin Sales by Country
  2. 10.1.1 South America Subcutaneous Injection Immunoglobulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Subcutaneous Injection Immunoglobulin Sales by Country (2021-2026)
  4. 10.1.3 South America Subcutaneous Injection Immunoglobulin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Subcutaneous Injection Immunoglobulin Market Size by Country
  6. 10.2.1 South America Subcutaneous Injection Immunoglobulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Subcutaneous Injection Immunoglobulin Market Size by Country (2021-2026)
  8. 10.2.3 South America Subcutaneous Injection Immunoglobulin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Subcutaneous Injection Immunoglobulin Sales by Country
  2. 11.1.1 Middle East and Africa Subcutaneous Injection Immunoglobulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Subcutaneous Injection Immunoglobulin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Subcutaneous Injection Immunoglobulin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Subcutaneous Injection Immunoglobulin Market Size by Country
  6. 11.2.1 Middle East and Africa Subcutaneous Injection Immunoglobulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Subcutaneous Injection Immunoglobulin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Subcutaneous Injection Immunoglobulin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Subcutaneous Injection Immunoglobulin Value Chain Analysis
  2. 12.1.1 Subcutaneous Injection Immunoglobulin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Subcutaneous Injection Immunoglobulin Production Mode & Process
  7. 12.2 Subcutaneous Injection Immunoglobulin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Subcutaneous Injection Immunoglobulin Distributors
  10. 12.2.3 Subcutaneous Injection Immunoglobulin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst